Institutional shares held 30.9 Million
121K calls
55.6K puts
Total value of holdings $190M
$741K calls
$341K puts
Market Cap $420M
68,350,896 Shares Out.
Institutional ownership 45.22%
# of Institutions 174


Latest Institutional Activity in CDXC

Top Purchases

Q3 2025
Ubs Group Ag Shares Held: 1.2M ($7.34M)
Q3 2025
Millennium Management LLC Shares Held: 774K ($4.75M)
Q3 2025
Algert Global LLC Shares Held: 572K ($3.51M)
Q3 2025
Charles Schwab Investment Management Inc Shares Held: 571K ($3.51M)
Q3 2025
Dimensional Fund Advisors LP Shares Held: 726K ($4.46M)

Top Sells

Q3 2025
D. E. Shaw & Co., Inc. Shares Held: 546K ($3.35M)
Q3 2025
Invesco Ltd. Shares Held: 34K ($208K)
Q3 2025
Janus Henderson Group PLC Shares Held: 24.4K ($150K)
Q3 2025
Connor, Clark & Lunn Investment Management Ltd. Shares Held: 628K ($3.86M)
Q3 2025
Lazard Asset Management LLC Shares Held: 27.3K ($167K)

About CDXC

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.


Insider Transactions at CDXC

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
73.6K Shares
From 3 Insiders
Open market or private purchase 6.96K shares
Exercise of conversion of derivative security 66.7K shares
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on CDXC

Follow ChromaDex Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDXC shares.

Notify only if

Insider Trading

Get notified when an Chroma Dex Corp. insider buys or sells CDXC shares.

Notify only if

News

Receive news related to ChromaDex Corp.

Track Activities on CDXC